Dupixent 300MG/2 ML 2S
Ended Awarded
- Contract number
- SPE2DR26FBATL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,588
Award facts
- Contract value 100% obligated
- $33,587.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $33,587.71 delivery order to AmerisourceBergen Drug Corp on June 1, 2026, for Dupixent 300mg/2mL injectables with an ultimate completion date of June 2, 2026.
Place of performance is Conshohocken, PA. The order is priced as firm fixed-price with no set-aside. The source does not identify a parent vehicle by name; the delivery order appears to call against DLA Troop Support Medical pharmaceutical procurement lines under which AmerisourceBergen holds standing indefinite delivery contracts.
Quick answers
Who was awarded contract SPE2DR26FBATL?
SPE2DR26FBATL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 1, 2026.
How much is contract SPE2DR26FBATL worth?
The government has obligated $33,588 on SPE2DR26FBATL.
Is contract SPE2DR26FBATL an order under another contract?
Yes. SPE2DR26FBATL is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FBATL competed?
The extent of competition for SPE2DR26FBATL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award